Now Reading
Israeli study assesses the impact of 2nd COVID-19 booster dose in elderly
Subscribe
Sign In

Israeli study assesses the impact of 2nd COVID-19 booster dose in elderly

Scientists study impact of 2nd booster dose. Lower COVID-19 rates found among elderly.

Where: World

The Facts

A study has found that a 2nd booster dose of the Pfizer-BioNTech COVID-19 vaccine reduces the rate of infection among those aged 60+.
However, according to the study, this initial protection begins to wane after a period of four weeks. Nonetheless, protection against severe illness did not diminish in the six weeks after the 2nd booster dose had been administered.
The study was published in the New England Journal of Medicine on Tuesday, with the research team noting that a follow-up study was required to assess the longer-term protection levels of the 2nd booster.
In this study, scientists studied the impact of the 2nd booster dose of the Pfizer-BioNTech vaccine on a test group of 1.3 million people aged 60 and older.
The data was obtained from Israel’s Ministry of Health database between January 10th and March 2nd, when the Omicron variant of COVID-19 was prevalent.

Primary Sources

Direct, authoritative source material on this story.

Reference Articles

Articles Citable has ingested related to this story.

Reference Articles

Articles Citable has ingested related to this story.

Media Coverage

Why did we include this story

Most covered story by the media today

of articles referenced this story

Coverage by Media Outlet

Media outlets covering this story along with their positive or negative sentiment toward this story.

© 2021 Citable. All Rights Reserved.